国药现代：全资子公司国药威奇达注射用哌拉西林钠新增规格并通过一致性评价

Core Insights - The article reports that China National Pharmaceutical Group Modern has received approval from the National Medical Products Administration for a supplemental application regarding the injectable drug Piperacillin Sodium, which now includes new specifications of 1.0g and has passed the consistency evaluation for generic drug quality and efficacy [2] Group 1 - The approval allows for the addition of new specifications (1.0g) for Piperacillin Sodium [2] - The drug is primarily used for treating infections caused by sensitive Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter species, including sepsis and complex urinary tract infections [2]